| Company Name: | Henry Schein, Inc. | | Ticker Symbol: | HSIC | | | WWW Address: | www.henryschein.com | | CEO: | Stanley M. Bergman | | No. of Employees: | 12,500 | | Common Issue Type: | CS | | Business Description: | The Company is a distributor of healthcare products and services to office-based healthcare practitioners in the combined North American and European markets.
|
| | | Industry Information: | WHOLESALE - Medical Equipment Wholesale [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 51.17 |  -0.45 | 50.56 | 51.76 | 51.4 | 51.59 | 50.96 | 502260 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 4,630.9 | 90.5 | 0.77 | 2.67 | 0.00 | 16.5 | 0.0 | 56.92 - 32.18 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 51.17 | $ | | PE Ratio - LTM | 16.5 | |
| Market Capitalisation | 4,630.0 | mil |
| Latest Shares Outstanding | 90.5 | mil |
| Earnings pS (EPS) | 2.67 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 511,590 | $ |
| Effective Tax Rate | 32.8 | % |
| Float | 88.4 | mil |
| Float as % of Shares Outstanding | 98.0 | % |
| Foreign Sales | 2,483 | mil |
| Domestic Sales | 3,912 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 22.10 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 30.7 | % |
| EBITDA Margin | 8.6 | % |
| Pre-Tax Profit Margin | 7.0 | % |
| Assets Turnover | 1.8 | % |
| Return on Assets (ROA) | 8.0 | % |
| Return on Equity (ROE) | 14.8 | % |
| Return on Capital Invested (ROCI) | 13.2 | % |
| Current Ratio | 2.0 | |
| Leverage Ratio (Assets/Equity) | 1.8 | |
| Interest Cover | 17.9 | |
| Total Debt/Equity (Gearing Ratio) | 0.13 | |
| LT Debt/Total Capital | 11.0 | % |
| Working Capital pS | 11.61 | $ |
| Cash pS | 3.51 | $ |
| Book-Value pS | 22.24 | $ |
| Tangible Book-Value pS | 9.10 | $ |
| Cash Flow pS | 4.22 | $ |
| Free Cash Flow pS | 3.02 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.30 | |
| Price/Tangible Book Ratio | 5.62 | |
| Price/Cash Flow | 12.1 | |
| Price/Free Cash Flow | 16.9 | |
| P/E as % of Industry Group | 41.0 | % |
| P/E as % of Sector Segment | 89.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.3 | 100 | 6,927 | 13,903 |
| 4 Weeks | 54.40 | 49.52 | 52.83 | -3.1 | 91 | 9,589 | 163,021 |
| 13 Weeks | 56.92 | 49.52 | 52.60 | -2.7 | 90 | 7,298 | 445,203 |
| 26 Weeks | 56.92 | 43.59 | 45.54 | 12.4 | 93 | 7,636 | 954,482 |
| 52 Weeks | 56.92 | 32.18 | 35.73 | 43.2 | 116 | 8,824 | 2,197,125 |
| YTD | 56.92 | 33.55 | - | 39.5 | 114 | 8,744 | 1,984,950 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 51.36 | 51.80 | 53.99 | 50.27 | 47.00 | 0.77 | 0.73 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 10.27 | 95.1 | 7.48 |
| Income | 15.98 | 96.5 | 18.25 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 6.33 | NA | 13.88 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 18.27 | NA | 18.16 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -1.4 | 0.5 | 8.0 |
| Earnings % | 29.1 | 47.2 | 13.0 |
| EPS % | 22.2 | 40.0 | 13.1 |
| EPS $ | 0.45 | 0.30 | 0.31 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 24.52 |
| Current Ratio | 1.7 |
| Quick Ratio (Acid Test) | 0.9 |
| Liquidity Ratio (Cash) | 0.31 |
| Receivables Turnover | 8.9 |
| Average Collection Period | 40 |
| Working Capital/Equity | 45.7 |
| Working Capital pS | 9.88 |
| Cash-Flow pS | 3.60 |
| Free Cash-Flow pS | 2.30 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 4.26 |
| Financial Leverage Ratio (Assets/Equity) | 1.9 |
| Debt Ratio | 46.3 |
| Total Debt/Equity (Gearing Ratio) | 0.22 |
| LT Debt/Equity | 0.14 |
| LT Debt/Capital Invested | 22.0 |
| LT Debt/Total Liabilities | 16.0 |
| Interest Cover | 14.0 |
| Interest/Capital Invested | 1.22 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 8.26 |
| Tobin's Q Ratio | 1.29 |
| Current P/E Ratio - LTM | 16.50 |
| Enterprise Value (EV)/EBITDA | 11.38 |
| Enterprise Value (EV)/Free Cash Flow | 51.90 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 5.62 |
| Price/Book Ratio - LTM | 2.30 |
| Price/Cash Flow Ratio | 12.1 |
| Price/Free Cash Flow Ratio - LTM | 16.9 |
| Price/Sales Ratio | 0.73 |
| P/E Ratio (1 month ago) - LTM | 17.8 |
| P/E Ratio (26 weeks ago) - LTM | 16.8 |
| P/E Ratio (52 weeks ago) - LTM | 12.4 |
| 5-Y High P/E Ratio | 29.7 |
| 5-Y Low P/E Ratio | 12.0 |
| 5-Y Average P/E Ratio | 23.3 |
| Current P/E Ratio as % of 5-Y Average P/E | 70 |
| P/E as % of Industry Group | 41.0 |
| P/E as % of Sector Segment | 89.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 14.8 |
| PER SHARE FIGURES |
| LT Debt pS | 2.98 |
| Current Liabilities pS | 13.25 |
| Tangible Book Value pS - LTM | 9.10 |
| Book Value pS - LTM | 22.24 |
| Capital Invested pS | 24.30 |
| Cash pS - LTM | 3.51 |
| Cash Flow pS - LTM | 4.22 |
| Free Cash Flow pS - LTM | 3.02 |
| Earnings pS (EPS) | 2.67 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 3.21 |
| Free Cash Flow Margin 5YEAR AVG | 1.39 |
| Net Profit Margin | 3.8 |
| Net Profit Margin - 5YEAR AVRG. | 3.4 |
| Equity Productivity | 3.31 |
| Return on Equity (ROE) | 12.6 |
| Return on Equity (ROE) - 5YEAR AVRG. | 12.0 |
| Capital Invested Productivity | 2.91 |
| Return on Capital Invested (ROCI) | 11.1 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 9.3 |
| Assets Productivity | 1.80 |
| Return on Assets (ROA) | 6.8 |
| Return on Assets (ROA) - 5YEAR AVRG. | 6.1 |
| Gross Profit Margin | 30.7 |
| Gross Profit Margin - 5YEAR AVRG. | 29.8 |
| EBITDA Margin - LTM | 8.6 |
| EBIT Margin - LTM | 7.4 |
| Pre-Tax Profit Margin | 6.3 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 5.9 |
| Effective Tax Rate | 32.8 |
| Effective Tax Rate - 5YEAR AVRG. | 35.1 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 98 |
| Revenue per Employee | 511,590 |
| Net Income per Employee | 19,451 |
| Average Collection Period | 41 |
| Receivables Turnover | 8.9 |
| Day's Inventory Turnover Ratio | 57 |
| Inventory Turnover | 6.3 |
| Inventory/Sales | 11.4 |
| Accounts Payble/Sales | 8.68 |
| Assets/Revenue | 0.56 |
| Net Working Capital Turnover | 7.25 |
| Fixed Assets Turnover | 4.17 |
| Total Assets Turnover | 1.8 |
| Revenue per $ Cash | 17.30 |
| Revenue per $ Plant | 25.80 |
| Revenue per $ Common Equity | 3.31 |
| Revenue per $ Capital Invested | 2.91 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 22.5 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 22.4 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |